Literature DB >> 14729734

Mutations of the rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan.

J-Y Chen1, Chang-Phone Fung, Feng-Yee Chang, Li-Yueh Huang, Jen-Chang Chang, L K Siu.   

Abstract

OBJECTIVE: To determine the mechanism of rifampicin resistance in Streptococcus pneumoniae in Taiwan.
METHODS: Rifampicin resistance was investigated with respect to the rpoB gene in 23 invasive S. pneumoniae isolates collected from 1996 to 2001. PCR and molecular typing were used for genetic and epidemiological analyses. Transformation was used to determine the functional gene for resistance.
RESULTS: Twenty-two of 23 isolates carried at least one mutation at either cluster I or III of rpoB; the most frequent mutation found in 21 isolates (91%) was histidine (H499) to asparagine or tyrosine at position 499, followed by isoleucine to valine (I624V) at position 624 in 16 isolates (70%), tyrosine to phenylalanine (Y589F) at position 589 in 14 isolates (60.9%) and isoleucine to valine (I608V) at position 608 in 13 isolates (56.5%). Less-frequent mutations were also identified: D489V, R597F, N623E, N623S, N669D, Q671K, Y674F and A683V. High-level rifampicin resistance was observed in isolates with a mutation at position 499 or 489. Mutations other than at position 499 or 489 played little role in or had no relation to rifampicin resistance. No dominant epidemic strain was observed with ribotyping, multilocus sequence typing, or serotyping.
CONCLUSIONS: Rifampicin resistance among multidrug-resistant S. pneumoniae in Taiwan was mostly caused by rpoB mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729734     DOI: 10.1093/jac/dkh073

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes.

Authors:  Steve Mullin; David M Rothstein; Christopher K Murphy
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.

Authors:  María José Ferrándiz; Carmen Ardanuy; Josefina Liñares; José María García-Arenzana; Emilia Cercenado; Ana Fleites; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.

Authors:  Aashish Srivastava; David Degen; Yon W Ebright; Richard H Ebright
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

4.  Differences in virulence of pneumolysin and autolysin mutants constructed by insertion duplication mutagenesis and in-frame deletion in Streptococcus pneumoniae.

Authors:  Esther Yip-Mei Liu; Feng-Yee Chang; Jen-Chang Chang; Chang-Phone Fung
Journal:  BMC Biotechnol       Date:  2014-02-21       Impact factor: 2.563

5.  Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation.

Authors:  Adam B Olson; Heather Kent; Christopher D Sibley; Margot E Grinwis; Philip Mabon; Claude Ouellette; Shari Tyson; Morag Graham; Shaun D Tyler; Gary Van Domselaar; Michael G Surette; Cindi R Corbett
Journal:  BMC Genomics       Date:  2013-12-17       Impact factor: 3.969

6.  Molecular Characterization of Rifampicin-Resistant Staphylococcus aureus Isolates from Retail Foods in China.

Authors:  Jiahui Huang; Feng Zhang; Jumei Zhang; Jingsha Dai; Dongli Rong; Miao Zhao; Juan Wang; Yu Ding; Moutong Chen; Liang Xue; Qihui Gu; Shi Wu; Qingping Wu
Journal:  Antibiotics (Basel)       Date:  2021-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.